Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Marpai, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2023 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Maestro Health, LLC. and Subsidiaries Consolidated Financial Statements Years Ended December 31, 2021 and 2020 Mazars USA LLP is an independent member firm of Mazars Group. Maestro Health, LLC. and Subsidiaries",
"Maestro Health, LLC. and Subsidiaries Consolidated Financial Statements Nine Months Ended September 30, 2022 Maestro Health, LLC. and Subsidiaries",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction The following unaudited pro forma condensed combined financial information is based on the historical consolidated financial statements of Marpai, Inc. and Maestro Health, LLC , after giving effect to Marpai’s acquisition of Maestro. The notes to the unaudited pro forma condensed combined financial information describe the reclassifications and transaction accounting adjustments to the financial information presented. Hereinafter, Marpai and Maestro are collectively referred to as the “Companies,” and the Companies, subsequent to the Acquisition, are referred to herein as the “Combined Company.” The following unaudited pro forma condensed combined financial information has been prepared in..." |
|
|
|